Teleflex

OverviewSuggest Edit

Teleflex Incorporated is a global provider of medical technologies designed to improve the health and quality of people’s lives. The Company applies purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Teleflex's portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care.

TypePublic
Founded1943
HQMorrisville, NC, US
Websiteteleflex.com
Employee Ratings4.1
Overall CultureB+

Latest Updates

Employees (est.) (Dec 2019)14,400(-5%)
Job Openings321
Revenue (FY, 2020)$2.5 B(-2%)
Share Price (Jun 2022)$258(+3%)
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Teleflex

Petro Barchuk

Petro Barchuk

Vice President of Financial Planning and Analysis
Karen Boylan

Karen Boylan

Corporate Vice President, Strategic Projects
Howard Cyr

Howard Cyr

Corporate Vice President and Chief Compliance Officer
Michael Digiuseppe

Michael Digiuseppe

President, Latin America and Americas Commercial Operations Group
John Deren

John Deren

Corporate Vice President and Chief Accounting Officer
James Ferguson

James Ferguson

President and General Manager, Surgical
Show more

Teleflex Office Locations

Teleflex has offices in Morrisville, Hapeville, Mascot, Wien and in 22 other locations
Morrisville, NC, US (HQ)
3015 Carrington Mill Blvd
Hapeville, GA, US
Atlanta Ave
Mascot, AU
Level 4, 197 Coward St
Wien, AT
Lazarettgasse 24
Beijing, CN
Unit 208, 2/F, One Indigo No. 20 Jiuxiangiao Road Chaoyang District
Hradec Králové, CZ
Pražská třída 209/182
Show all (27)

Teleflex Financials and Metrics

Teleflex Revenue

Embed Graph
View revenue for all periods
Teleflex's revenue was reported to be $2.54 b in FY, 2020
USD

Revenue (Q1, 2021)

633.9m

Gross profit (Q1, 2021)

344.5m

Gross profit margin (Q1, 2021), %

54.3%

Net income (Q1, 2021)

74.9m

EBIT (Q1, 2021)

103.4m

Market capitalization (24-Jun-2022)

12.1b

Closing stock price (24-Jun-2022)

258.0

Cash (28-Mar-2021)

324.6m

EV

14.2b
Teleflex's current market capitalization is $12.1 b.
Annual
USDFY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

201.1m323.3m(190.1m)151.7m188.8m245.7m237.8m152.5m200.8m461.5m335.3m

Depreciation and Amortization

48.4m41.5m94.9m42.4m50.2m46.0m54.4m155.3m60.5m214.1m227.3m

Inventories

(3.7m)(32.7m)(2.0m)(8.9m)(15.5m)(8.4m)6.4m(22.4m)(37.2m)(53.2m)(5.5m)

Accounts Payable

(1.3m)(248.0k)(1.5m)(684.0k)9.8m(117.0k)15.4m39.0m62.4m36.0m646.0k
USDQ2, 2010

Debt/Equity

0.7 x

Debt/Assets

0.3 x

Financial Leverage

2.4 x
Show all financial metrics

Teleflex Cybersecurity Score

Cybersecurity ratingPremium dataset

B

88/100

SecurityScorecard logo

Teleflex Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

50-59

out of 100

CSRHub logo

Teleflex Online and Social Media Presence

Embed Graph

Teleflex Company Culture

  • Overall Culture

    B+

    74/100

  • CEO Rating

    A+

    83/100

  • Compensation

    D

    52/100

Learn more on Comparably

Teleflex News and Updates

Teleflex launches new Arrow Pressure Injectable Midline Catheter in Australia and New Zealand

Designed to help clinicians overcome catheter identification confusion Designed to help clinicians overcome catheter identification confusion

Teleflex launches new Arrow Pressure Injectable Midline Catheter in Europe, the Middle East and Africa region

Designed to help clinicians overcome catheter identification confusion Designed to help clinicians overcome catheter identification confusion

Teleflex Announces Regulatory Clearance for its UroLift® System in China for the Treatment of Benign Prostatic Hyperplasia (BPH)

Will expand patient access to BPH treatment Will expand patient access to BPH treatment

Teleflex Announces Health Canada Approval of MANTA® Vascular Closure Device

WAYNE, Pa., May 18, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today has announced that it received Health Canada approval for the MANTA® Vascular Closure Device – the first commercially available biomechanical vascular closure de…

Outlook on the Catheter Global Market to 2027 - Featuring Teleflex, Boston Scientific and Terumo Among Others

DUBLIN, May 13, 2022 /PRNewswire/ -- The "Global Catheter Market, Size, Share, Forecast 2022-2027, Industry Trends, Growth, Outlook, Impact of COVID-19, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering. This report provides an all-encompassing...

Teleflex to Host Analyst & Investor Day on May 20, 2022

WAYNE, Pa., May 02, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced that the Company will host an Analyst & Investor Day on Friday, May 20, 2022 in New York City. Liam Kelly, Chairman, President and CEO, will be joined by members of the Company’s Lead…
Show more

Teleflex Frequently Asked Questions

  • When was Teleflex founded?

    Teleflex was founded in 1943.

  • Who are Teleflex key executives?

    Teleflex's key executives are Petro Barchuk, Karen Boylan and Howard Cyr.

  • How many employees does Teleflex have?

    Teleflex has 14,400 employees.

  • What is Teleflex revenue?

    Latest Teleflex annual revenue is $2.5 b.

  • What is Teleflex revenue per employee?

    Latest Teleflex revenue per employee is $176.2 k.

  • Who are Teleflex competitors?

    Competitors of Teleflex include Inari Medical, Sonova and Medartis Holding.

  • Where is Teleflex headquarters?

    Teleflex headquarters is located at 3015 Carrington Mill Blvd, Morrisville.

  • Where are Teleflex offices?

    Teleflex has offices in Morrisville, Hapeville, Mascot, Wien and in 22 other locations.

  • How many offices does Teleflex have?

    Teleflex has 27 offices.